Fit for the Future: Familiar Promises in a New NHS Plan

The government’s new 10 Year Health Plan, Fit for the Future, was published on 3 July 2025. Heralded as a bold statement of intent, it promises three radical shifts: hospital to community, analogue to digital, and sickness to prevention. Yet for all its language of transformation, much of what is proposed feels more like a reprise than a revolution.

The emphasis on prevention is a case in point. Far from being a fresh innovation, prevention has been part of the health service’s DNA since its inception. The NHS Act of 1946 highlighted its importance, while the 1976 government paper Prevention and Health explored strategies to tackle public health issues. In more recent decades, prevention has been the theme of numerous initiatives on obesity, smoking, and wider health inequalities. The question is not whether prevention should be central, but why, after so many years of focus, the outcomes remain mixed.

The shift from hospital to community also has a long pedigree. The plan’s promise to increase the proportion of spending in community settings repeats aspirations first laid out in Our Health, Our Care, Our Say in 2006. At the time, such ambitions were underpinned by a belief in more integrated, localised provision. Yet as the Darzi review later concluded, NHS spending in practice has moved in the opposite direction, with hospitals receiving an ever-greater share of the budget. The new proposals for ‘neighbourhood health centres’ open six days a week echo the health centres envisioned in 1946, the walk-in centres of the 2000s, and the polyclinics of the Darzi Report in 2007. The recycled language raises a pressing issue: why have previous attempts failed, and what confidence should the public place in this latest promise?

Digital transformation, too, is presented as if it were an untapped frontier. In reality, the NHS has pursued such projects for decades, not least the costly and ill-fated Connecting for Health programme of 2005. Today, hope is pinned on the NHS App, which is intended to become the ‘front door’ to all NHS services by 2028. Yet memories of the troubled Covid App remain fresh, and the dangers of a digital divide are plain. During the pandemic, older patients, those with limited access to technology, and disadvantaged groups often struggled with digital solutions. Without serious attention to inclusivity, there is a real risk of policies inadvertently breaching the Equality Act 2010 in relation to protected characteristics such as age.

Perhaps most striking is the plan’s declared ‘one core purpose’: to put power in patients’ hands. This, too, is hardly new. Patient empowerment has been a stated goal of successive Secretaries of State, while New Labour’s era was marked by league tables, earned autonomy, and partnerships with the private sector. The current plan revives these tools, with a promise to ‘reinvent’ Foundation Trusts and to continue using independent capacity for NHS patients. Where it diverges from New Labour is in resources and attitude. Unlike Blair’s government, this strategy does not rest on new financial investment, signalling that the era of “more money, never reform” is, in the government’s words, over. Moreover, the document shows little curiosity about why earlier versions of these policies failed, leaving the impression that the same remedies are being applied in the hope of different results.

As Professor Martin Powell of the University of Birmingham observes, the three shifts so heavily trailed by ministers have featured in NHS strategies for generations. The danger now is that Fit for the Future becomes less a blueprint for transformation and more a tribute act, replaying familiar tunes without learning from the past. For a plan so ambitious in tone, its success will depend not on how radical its language appears, but on whether it finally confronts the reasons so many similar initiatives have stumbled before.

Read the original blog here: https://www.birmingham.ac.uk/news/2025/the-10-year-health-plan-something-old-little-new-something-borrowed-something-blue

Author

Leave A Comment

Shabna Raja

Advisory Partner,
Life Sciences Week
+44 (0) 121 227 4156
info@lifesciencesweek.co.uk

Bio

Shabna Raja is a senior leader in enterprise transformation within Life Sciences, with over 20 years’ experience spanning pharma, consumer health and large-scale digital programmes.

She specialises in bridging strategy and execution – helping organisations translate AI, data and digital innovation into tangible business outcomes. Her work focuses on complex transformation
initiatives across commercial, data and operating model domains within regulated environments.

Shabna spent seven years at GSK, where she played a key role in transformation programmes, including as part of the Consumer Health joint venture with Pfizer — one of the most significant integrations in the sector. This experience provided her with deep expertise in  organisational change, integration and operating model evolution at global scale.

More recently, she has spent over three years working closely with Haleon through a strategic
services partnership, leading enterprise client engagement and managing a multi-million-pound account while supporting transformation across a newly independent global organisation.

Her experience spans the end-to-end life sciences value chain, including R&D, commercial, supply chain and patient engagement, giving her a holistic perspective on how technology and transformation can unlock value across the industry.

Amjad Khan

Executive Partner,
Life Sciences Week
+44 (0) 121 227 4156
info@lifesciencesweek.co.uk

Bio

Amjad Khan is a UK-based entrepreneur, AI strategist, and senior technology leader with over 15 years of experience at Pfizer, where he held multiple leadership roles across digital strategy and transformation. As Global Digital Client Partner, he was responsible for digital strategy and execution across Global Business Units covering Vaccines, Hospital, and Medical Affairs. Most notably, he led the commercial launch for the Covid franchise transforming and accelerating the model for how new medicines are brought to market.

Following his tenure at Pfizer, Amjad channelled his expertise into building at the frontier of AI. His work spans AI leadership, stakeholder engagement, and agile delivery helping organisations adopt
and scale emerging  technologies to drive meaningful outcomes.

Dr. Richard Fallon | Business Consultant | WM Life Sciences

Dr. Richard Fallon

Co Founder, Life Sciences Week 
+44 (0) 121 227 4156
info@lifesciencesweek.co.uk

Bio

Dr Richard Fallon is an entrepreneur and ecosystem builder who connects industry leaders, investors and public-sector stakeholders to accelerate collaboration and commercial growth.

As the Founder of the Technology Supply Chain and co-founder of the Innovation Awards, he has spent more than two decades convening influential networks that help emerging businesses find capital, strategic partners and new routes to market.

Richard’s work spans leadership and consultancy across major organisations, alongside building membership and partnership platforms that bring universities, industry and investors into the same room – and turn conversations into practical outcomes.

With his focus on life sciences, Richard supports organisations and people driving breakthroughs in healthcare, biotechnology, medical technology and advanced research. He is passionate about creating the conditions for transformative ideas to move from concept to real-world impact – by connecting innovators with the funding, expertise and opportunities they need to scale.

Through Life Sciences Week, Richard is championing the UK’s world-class life sciences community and helping position it at the forefront of innovation, investment and patient outcomes.

Paul Cadman | Executive Chairman | WM Life Sciences

Prof Paul Cadman

CEO of One Thousand Trades Group & Co-founder of Life Sciences Week,
Life Sciences Week
+44 (0) 121 227 4156
info@lifesciencesweek.co.uk

Bio

Prof. Paul Cadman is a nationally and internationally recognised, award-winning inclusive leader and “knowledge broker”, known for bringing people, ideas and organisations together to turn ambition into deliverable outcomes.

His experience spans Research, Technology, Manufacturing, Consultancy and Membership Organisations – giving him a rare ability to translate between sectors, priorities and professional cultures in a way that builds trust and unlocks progress.

Across his career, Paul has helped take concepts from inception through to scale, including initiatives that have generated £100m+ in turnover. He combines strategic thinking with an extensive network, supporting organisations to drive organic growth, forge partnerships and deliver meaningful business transformation. He is particularly valued for his ability to connect the right stakeholders at the right time, and create the conditions for collaboration to become action.

Through Life Sciences Week, Paul helps convene the communities shaping innovation – bringing together research, industry and investment to strengthen relationships, spotlight opportunity, and accelerate real-world impact.

Amy Deakin | Chief of Staff | WM Life Sciences

Amy Deakin

Event Managing Director,
Life Sciences Week
+44 (0) 121 227 4156
info@lifesciencesweek.co.uk

Bio

Amy Deakin is a Birmingham-based leader specialising in building partnerships and fostering innovation in the life sciences sector. With a degree in Sport and Exercise Science, Amy brings a grounded understanding of human health and performance to her work and a strong interest in the developments shaping healthcare today.

Amy is Managing Director of Life Sciences Week, part of the One Thousand Trades Group, and also serves as Director of One Thousand Trades Events. In these roles, she convenes researchers, clinicians and industry leaders to strengthen collaboration, unlock new partnerships and help accelerate real-world innovation across the life sciences ecosystem.

Her career spans both commercial and third-sector environments. She began in automotive design, delivering projects for Volkswagen, McLaren, Bentley and Jaguar Land Rover, before moving into the third sector with Acorns Children’s Hospice. She later joined Western Union, working as a Partnerships Manager for international payments

An avid netballer, Amy is a committed advocate for health and wellbeing – bringing energy, clarity and connection to everything she builds, and actively involved as a participant in health related research studies.

    Award Category Voting

    Here's a list of all categories you can vote for. Simply click each category to cast your vote. Voting in each category is not mandatory, so please feel free to click just the category that interests you.

    Day you've not voted in, will be denoted with an ❌

    If you're having issues submitting the form, please ensure all the category boxes are closed and try again.

    Recognising pioneering research, technology, or therapies that are transforming healthcare and biotechnology.

    No VoteProf. Alex RichterBlack Space TechnologyAston Vision Sciences

    Celebrating an emerging leader making significant contributions to the field through research, innovation, or leadership.

    Recognising pioneering research, technology, or therapies that are transforming healthcare and biotechnology.

    No VoteShashank Chaganty – VichagLeah Vanono - PBS InnovationsKloe Avon- KZ Organics

    Honouring successful cross-sector partnerships driving advancements in life sciences, from academia to industry.

    No VoteProf Liam Grover- WMHTIAJudith Stewart- Health Innovation West MidlandsAdam McGuinness - Plug and Play

    Awarding an individual or organisation for exceptional long-term impact on the industry.

    No VoteDavid KidneyMedilink MidlandsUniversity of Birmingham

    Highlighting innovations in treatments, diagnostics, or healthcare delivery that have significantly improved patient outcomes.

    No VoteJean-Louis Duprey - Linear DiagnosticsSian Dunning - MD-TECKarim Vissangy - HoloMedix

    Your Details